Completed OBSERVATIONAL NCT02853292

Incidence, Risk Factors and Impact on Renal Function of the Appearance of Crystalluria Under High-dose Intravenous Amoxicillin (CRISTAMOX)

Sponsor: CHU de Reims

Updated 8 times since 2017 Last updated: Jun 3, 2022 Started: May 31, 2016 Primary completion: Aug 31, 2019 Completion: May 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Amoxicillin Crystalluria, this trial is completed. The trial is conducted by CHU de Reims and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jul 2022 — Jul 2024 [monthly]

Completed
Jan 2021 — Jul 2022 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Nov 2017 — Apr 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Nov 2017 [monthly]

Recruiting NA

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CHU de Reims

Data source: CHU de Reims

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Reims, France